Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans

By Bruderer Shirin   Hopfgartner Gérard   Seiberling Michael   Wank Janine   Sidharta Patricia N.   Treiber Alexander   Dingemanse Jasper  

Xenobiotica, Vol. 42, Iss. 9, 2012-09 ,pp. : 901-910

Informa Healthcare

Access to resources Recommend Favorite

The disposition and metabolism of zibotentan (ZD4054): an oral-specific endothelin A receptor antagonist in mice, rats and dogs

By Clarkson-Jones J.A.   Kenyon A.S.J.   Tomkinson H.K.  

Xenobiotica, Vol. 41, Iss. 9, 2011-09 ,pp. : 784-796

Informa Healthcare

Access to resources Recommend Favorite

Disposition and metabolism of the specific endothelin A receptor antagonist zibotentan (ZD4054) in healthy volunteers

By Clarkson-Jones Jacqueline A.   Kenyon Alison S.J.   Kemp John   Lenz Eva M.   Oliver Stuart D.   Swaisland Helen  

Xenobiotica, Vol. 42, Iss. 4, 2012-04 ,pp. : 363-371

Informa Healthcare

Access to resources Recommend Favorite

In vitro metabolism of the specific endothelin-A receptor antagonist ZD4054 and clinical drug interactions between ZD4054 and rifampicin or itraconazole in healthy male volunteers

By Swaisland H. C.   Oliver S. D.   Morris T.   Jones H. K.   Bakhtyari A.   Mackey A.   McCormick A. D.   Slamon D.   Hargreaves J. A.   Millar A.   Taboada M. T.  

Xenobiotica, Vol. 39, Iss. 6, 2009-06 ,pp. : 444-456

Informa Healthcare

Access to resources Recommend Favorite

Antagonist Binding Characteristics of the Ser311-

By Pohjalainen T.   Cravchik A.   Gejman P.V.   Rinne J.   Nagren K.   Syvalahti E.   Hietala J.  

Biochemical and Biophysical Research Communications, Vol. 232, Iss. 1, 1997-03 ,pp. : 143-146

Elsevier

Access to resources Recommend Favorite